“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises

Abstract Background Since the onset of the COVID-19 pandemic, overdose rates in North America have continued to rise, with more than 100,000 drug poisoning deaths in the past year. Amidst an increasingly toxic drug supply, the pandemic disrupted essential substance use treatment and harm reduction s...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Kaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, Kurt Lock, Adam Easterbrook, Scott MacDonald, Scott Harrison, Julie Lajeunesse, David Byres, Martin Schechter, Eugenia Oviedo-Joekes
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2023-04-01
Saila:	Harm Reduction Journal
Gaiak:	Injectable opioid agonist treatment COVID-19 pandemic Substance use Canada
Sarrera elektronikoa:	https://doi.org/10.1186/s12954-023-00779-w
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!